— Know what they know.
Not Investment Advice

TECH Short Interest

Bio-Techne Corporation
1W: +0.3% 1M: +0.1% 3M: +0.9% YTD: +22.0% 1Y: +10.2% 3Y: +15.8% 5Y: -40.7%
$72.63
-0.06 (-0.08%)
 
Weekly Expected Move ±0.3%
$72 $72 $73 $73 $73
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 64 · $11.4B mcap · 156M float · 2.71% daily turnover · Short 51% of daily vol
Credit Risk of going bust: lower than 84% of companies Debt: 2.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.12 (down 99.8%), Bio-Techne Corporation would be worth roughly what it owes.
Total debt $289.1M against a stock market value of $11.40B.
Distance to default 10.93 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $100.0M (short-term plus half of long-term), stock volatility 43.3%; Altman Z'' 8.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
51.7%
Short Ratio
of total volume
43.0%
20-Day Avg
36.0%
50-Day Avg
▲ Rising
5-Day Trend
0.2M
Short Volume
0.4M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 212,566 417,638 50.9%
NYSE 10,562 17,550 60.2%
BATS 4,012 4,458 90.0%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms